BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 35764885)

  • 1. Dicer deficiency impairs proliferation but potentiates anti-tumoral effect of macrophages in glioblastoma.
    Liu YQ; Luo M; Shi Y; Guo Y; Zhang H; Yang KD; Li TR; Yang LQ; Liu TT; Huang B; Liu Q; He ZC; Zhang XN; Wang WY; Wang S; Zeng H; Niu Q; Zhang X; Cui YH; Zhang ZR; Bian XW; Ping YF
    Oncogene; 2022 Jul; 41(30):3791-3803. PubMed ID: 35764885
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Single-Cell Atlas Reveals Complexity of the Immunosuppressive Microenvironment of Initial and Recurrent Glioblastoma.
    Fu W; Wang W; Li H; Jiao Y; Huo R; Yan Z; Wang J; Wang S; Wang J; Chen D; Cao Y; Zhao J
    Front Immunol; 2020; 11():835. PubMed ID: 32457755
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Programmed Cell Death 10 Mediated CXCL2-CXCR2 Signaling in Regulating Tumor-Associated Microglia/Macrophages Recruitment in Glioblastoma.
    Zhang Q; Wang J; Yao X; Wu S; Tian W; Gan C; Wan X; You C; Hu F; Zhang S; Zhang H; Zhao K; Shu K; Lei T
    Front Immunol; 2021; 12():637053. PubMed ID: 34108959
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Exploiting Microglial Functions for the Treatment of Glioblastoma.
    Dello Russo C; Lisi L; Tentori L; Navarra P; Graziani G; Combs CK
    Curr Cancer Drug Targets; 2017; 17(3):267-281. PubMed ID: 27528361
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Blood monocyte-derived CD169
    Kim HJ; Park JH; Kim HC; Kim CW; Kang I; Lee HK
    Nat Commun; 2022 Oct; 13(1):6211. PubMed ID: 36266311
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeting glioblastoma with NK cells and mAb against NG2/CSPG4 prolongs animal survival.
    Poli A; Wang J; Domingues O; Planagumà J; Yan T; Rygh CB; Skaftnesmo KO; Thorsen F; McCormack E; Hentges F; Pedersen PH; Zimmer J; Enger PØ; Chekenya M
    Oncotarget; 2013 Sep; 4(9):1527-46. PubMed ID: 24127551
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Loss of SOCS3 in myeloid cells prolongs survival in a syngeneic model of glioma.
    McFarland BC; Marks MP; Rowse AL; Fehling SC; Gerigk M; Qin H; Benveniste EN
    Oncotarget; 2016 Apr; 7(15):20621-35. PubMed ID: 26967393
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MerTK inhibition decreases immune suppressive glioblastoma-associated macrophages and neoangiogenesis in glioblastoma microenvironment.
    Su YT; Butler M; Zhang M; Zhang W; Song H; Hwang L; Tran AD; Bash RE; Schorzman AN; Pang Y; Yu G; Zamboni WC; Wang X; Frye SV; Miller CR; Maric D; Terabe M; Gilbert MR; Earp Iii HS; Wu J
    Neurooncol Adv; 2020; 2(1):vdaa065. PubMed ID: 32642716
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Single-cell profiling and zebrafish avatars reveal LGALS1 as immunomodulating target in glioblastoma.
    Finotto L; Cole B; Giese W; Baumann E; Claeys A; Vanmechelen M; Decraene B; Derweduwe M; Dubroja Lakic N; Shankar G; Nagathihalli Kantharaju M; Albrecht JP; Geudens I; Stanchi F; Ligon KL; Boeckx B; Lambrechts D; Harrington K; Van Den Bosch L; De Vleeschouwer S; De Smet F; Gerhardt H
    EMBO Mol Med; 2023 Nov; 15(11):e18144. PubMed ID: 37791581
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In Vitro Assay to Study Tumor-macrophage Interaction.
    An Z; Weiss WA
    J Vis Exp; 2019 Aug; (150):. PubMed ID: 31424440
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phytosomal curcumin causes natural killer cell-dependent repolarization of glioblastoma (GBM) tumor-associated microglia/macrophages and elimination of GBM and GBM stem cells.
    Mukherjee S; Fried A; Hussaini R; White R; Baidoo J; Yalamanchi S; Banerjee P
    J Exp Clin Cancer Res; 2018 Jul; 37(1):168. PubMed ID: 30041669
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PDIA3 Expression in Glioblastoma Modulates Macrophage/Microglia Pro-Tumor Activation.
    Chiavari M; Ciotti GMP; Canonico F; Altieri F; Lacal PM; Graziani G; Navarra P; Lisi L
    Int J Mol Sci; 2020 Nov; 21(21):. PubMed ID: 33153019
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differentiated glioblastoma cells accelerate tumor progression by shaping the tumor microenvironment via CCN1-mediated macrophage infiltration.
    Uneda A; Kurozumi K; Fujimura A; Fujii K; Ishida J; Shimazu Y; Otani Y; Tomita Y; Hattori Y; Matsumoto Y; Tsuboi N; Makino K; Hirano S; Kamiya A; Date I
    Acta Neuropathol Commun; 2021 Feb; 9(1):29. PubMed ID: 33618763
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Loss of CX3CR1 increases accumulation of inflammatory monocytes and promotes gliomagenesis.
    Feng X; Szulzewsky F; Yerevanian A; Chen Z; Heinzmann D; Rasmussen RD; Alvarez-Garcia V; Kim Y; Wang B; Tamagno I; Zhou H; Li X; Kettenmann H; Ransohoff RM; Hambardzumyan D
    Oncotarget; 2015 Jun; 6(17):15077-94. PubMed ID: 25987130
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intratumoral administration of the antisecretory peptide AF16 cures murine gliomas and modulates macrophage functions.
    Kopecky J; Pérez JE; Eriksson H; Visse E; Siesjö P; Darabi A
    Sci Rep; 2022 Mar; 12(1):4609. PubMed ID: 35301393
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effective Reprogramming of Patient-Derived M2-Polarized Glioblastoma-Associated Microglia/Macrophages by Treatment with GW2580.
    Fermi V; Warta R; Wöllner A; Lotsch C; Jassowicz L; Rapp C; Knoll M; Jungwirth G; Jungk C; Dao Trong P; von Deimling A; Abdollahi A; Unterberg A; Herold-Mende C
    Clin Cancer Res; 2023 Nov; 29(22):4685-4697. PubMed ID: 37682326
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of a unique tumor cell subset employing myeloid transcriptional circuits to create an immunomodulatory microenvironment in glioblastoma.
    Yang K; Shi Y; Luo M; Mao M; Zhang X; Chen C; Liu Y; He Z; Liu Q; Wang W; Luo C; Yin W; Wang C; Niu Q; Zeng H; Bian XW; Ping YF
    Oncoimmunology; 2022; 11(1):2030020. PubMed ID: 35096487
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immune cell infiltrate differences in pilocytic astrocytoma and glioblastoma: evidence of distinct immunological microenvironments that reflect tumor biology.
    Yang I; Han SJ; Sughrue ME; Tihan T; Parsa AT
    J Neurosurg; 2011 Sep; 115(3):505-11. PubMed ID: 21663411
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Loss of host-derived osteopontin creates a glioblastoma-promoting microenvironment.
    Szulzewsky F; Schwendinger N; Güneykaya D; Cimino PJ; Hambardzumyan D; Synowitz M; Holland EC; Kettenmann H
    Neuro Oncol; 2018 Feb; 20(3):355-366. PubMed ID: 29016864
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HYBID derived from tumor cells and tumor-associated macrophages contribute to the glioblastoma growth.
    Tsuji S; Nakamura S; Yamada T; de Vega S; Okada Y; Inoue S; Shimazawa M; Hara H
    Brain Res; 2021 Aug; 1764():147490. PubMed ID: 33887254
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.